REVELATION BIOSCIENCES INC (REVB) Stock Analyst Earnings Estimates
NASDAQ:REVB - Nasdaq - US76135L5075 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 111.03% | N/A 128.25% | N/A 45.72% | ||||||
| EBITDA YoY % growth | N/A | -2.531M | -11.934M -371.58% | -10.839M 9.17% | -8.632M 20.37% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.64K | -2.531M -69,421.98% | -11.951M -372.24% | -10.865M 9.09% | -8.657M 20.32% | N/A 4.43% | N/A -13.65% | N/A -1.25% | N/A -2.80% | N/A 358.76% | N/A 154.00% | N/A 148.42% | N/A 48.58% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -735.60 95.18% | 55.27 107.51% | N/A -1,047.92% | N/A 93.38% | N/A 52.51% | N/A 94.06% | N/A 1,433.33% | N/A 145.00% | N/A 141.84% | N/A 45.78% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -5.55 33.39% | -8.51 78.39% | 4.68 105.70% | 4.60 134.19% | -8.57 -54.41% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.15M 7.58% | -2.031M -6.77% | -2.143M 15.04% | -2.266M -26.15% | -2.4M -11.65% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -13.44 -6.67% | -46.35 | 32.91 | 71.00% |
| Q2 2024 Q2Q % growth | -82.08 -994.40% | -29.46 | -52.62 | -178.64% |
| Q1 2024 Q2Q % growth | -39.36 -147.03% | -87.88 | 48.52 | 55.21% |
| Q4 2023 Q2Q % growth | -8.33 84.31% | -14.05 | 5.72 | 40.69% |
| Q3 2023 Q2Q % growth | -12.60 80.00% | -9.18 | -3.42 | -37.25% |
| Q2 2023 Q2Q % growth | -7.50 94.05% | -12.24 | 4.74 | 38.73% |
| Q1 2023 Q2Q % growth | 83.70 116.96% | -19.89 | 103.59 | 520.81% |
| Q4 2022 Q2Q % growth | -53.10 | -53.55 | 0.45 | 0.84% |
| Q3 2022 Q2Q % growth | -63.00 | -96.39 | 33.39 | 34.64% |
| Q2 2022 Q2Q % growth | -126.00 | -149.94 | 23.94 | 15.97% |
| Q1 2022 Q2Q % growth | -493.50 | -149.94 | -343.56 | -229.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -688.41% | -688.41% | -6766.84% | -4413.53% |
| Revenue | N/A | N/A | N/A | N/A |